United States 119th Congress Status: In Committee Bipartisan · 45 D · 2 I cosponsors

SRES 732 — A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Last action — Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2309-2310)

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced May 14, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 42% · moderate confidence

  • In Committee

    Current position in the legislative process.

  • 47 sponsors

    1 primary, 46 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (45 D · 2 I) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

The resolution supports equitable access to mifepristone based on scientific evidence of its safety and efficacy.

This resolution expresses the Senate's view that mifepristone is proven safe and effective over 25 years. It calls for equitable access to medication abortion care in the U.S. based on scientific evidence.

What this means for you
  • Consumers: This resolution supports consumer access to mifepristone based on evidence of safety and effectiveness.

Bill Text

Action History

  1. Submitted in Senate

  2. Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2309-2310)

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 46 co-sponsors · 500 not signed on

Sponsors (1)

Co-sponsors (46)

Not signed on (500)

500 members have not signed on to this bill.

Show all 500 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

civil-rights healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SRES 732?
SRES 732 is sponsored by Baldwin, Tammy (Democratic), Schumer, Charles E. (Democratic), Wyden, Ron (Democratic), Murray, Patty (Democratic), Smith, Tina (Democratic), Alsobrooks, Angela D. (Democratic), Bennet, Michael F. (Democratic), Blumenthal, Richard (Democratic), Blunt Rochester, Lisa (Democratic), Booker, Cory A. (Democratic), Cantwell, Maria (Democratic), Coons, Christopher A. (Democratic), Cortez Masto, Catherine (Democratic), Duckworth, Tammy (Democratic), Durbin, Richard J. (Democratic), Fetterman, John (Democratic), Gallego, Ruben (Democratic), Gillibrand, Kirsten E. (Democratic), Hassan, Margaret Wood (Democratic), Heinrich, Martin (Democratic), Hickenlooper, John W. (Democratic), Hirono, Mazie K. (Democratic), Kaine, Tim (Democratic), Kelly, Mark (Democratic), Kim, Andy (Democratic), King, Angus S., Jr. (Independent), Klobuchar, Amy (Democratic), Luján, Ben Ray (Democratic), Markey, Edward J. (Democratic), Merkley, Jeff (Democratic), Murphy, Christopher (Democratic), Ossoff, Jon (Democratic), Padilla, Alex (Democratic), Peters, Gary C. (Democratic), Reed, Jack (Democratic), Rosen, Jacky (Democratic), Sanders, Bernard (Independent), Schatz, Brian (Democratic), Schiff, Adam B. (Democratic), Slotkin, Elissa (Democratic), Shaheen, Jeanne (Democratic), Van Hollen, Chris (Democratic), Warner, Mark R. (Democratic), Warnock, Raphael G. (Democratic), Welch, Peter (Democratic), Whitehouse, Sheldon (Democratic), and Warren, Elizabeth (Democratic).
What is the current status of SRES 732?
This bill is in committee in the Senate. Introduced May 14, 2026. It must pass committee before a floor vote.
Where can I track SRES 732?
Track SRES 732 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SRES 732

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SRES 732

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →